1 / 32

Risk assessment of nanotechnology

Risk assessment of nanotechnology. Wesley E. Smith, Ph.D. Senior Fellow CEEH. http://thereadingroom.epsilonfoundation.com.au/technology/nano-tech-godzilla/. Outline. What is nanotechnology? What is the state of nanotechnology risk assessment? What is happening at the UW?.

horace
Download Presentation

Risk assessment of nanotechnology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Risk assessment of nanotechnology Wesley E. Smith, Ph.D. Senior Fellow CEEH http://thereadingroom.epsilonfoundation.com.au/technology/nano-tech-godzilla/

  2. Outline • What is nanotechnology? • What is the state of nanotechnology risk assessment? • What is happening at the UW?

  3. What is nanotechnology?

  4. How big is a nanometer (nm)? • A humanhairdivided 100,000X • Sheet of paper is about 100,000 nmthick. • Blondhair is probably 15,000 to 50,000 nmin diameter, butblackhair is likely to bebetween 50,000 and 180,000 nm. • Thereare 25,400,000 nmin an inch. • A nanometer is a millionth of a millimeter (10-9) http://www.nano.gov/html/facts/whatIsNano.html

  5. http://www.nano.gov/html/facts/The_scale_of_things.html

  6. What is nanotechnology? • “Nanotechnology is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications” • Involves multiple disciplines, including science, engineering and technology • “Wet” –involving aqueous systems • “Dry”-surface chemistry, semiconductors • Computational-modeling nanosystems • Nanosized particles (NSPs)

  7. Promises of Nanotechnology Clean, secureaffordableenergy prototypesolarpanelsoffer the possibility of beingmoreefficient. Likewise, nanotechnology is beingemployed in fuelcelldevelopment CleanWater variousnanomaterialshold the potential for the detection of impurities (pollutants, microbes, etc), as well as removal of them http://www.nano.gov/html/facts/home_facts.html

  8. What is special (scary) aboutnano? • Unusualphysical, chemical, and biologicalcharacteristics at nanoscale • Individualnanoparticleshavedifferentpropertiesthanbulksolution • Greatersurfacearea/volume-potentiallymorereactive • Ability to manipulateindividualparticles

  9. Currentapplications of nanotech Nano-Care® StressfreeKhakis-(Gap)‏ “NanoémulsionPeauxSensibles Calming Emulsion”-(Chanel)‏ “The Samsung 65-nm 8-Gbit NAND flash (K9G8G08U0M)”-(Apple)‏ • Public inventory: http://www.nanotechproject.org/inventories/consumer/

  10. Where is nanotechnology? http://www.nanotechproject.org/maps/mappage.html

  11. What is the state of nanotechnology risk assessment?

  12. Donanomaterialspresent a risk to human and environmentalhealth? • The verysamephysical and chemicalcharacteristics of nanomaterialsthatgivepromise, alsohave the potential for peril. • Effectsarenotwellcharacterized. • Ultrafineparticles (UFPs) generallycausemoretoxicity in lungmodels • Reactivity of someparticlesincreases as surfacearea-volumeratioincreases • Represents a veryimportantneed for research.

  13. Key Words of Toxicology Dose / Response Hazard X Exposure = Risk Individual Susceptibility

  14. Key Words of Toxicology Dose / Response Hazard X Exposure = Risk Individual Susceptibility

  15. Who is at risk? • Humans • Workers • Consumers • Susceptible: elderly and children • Wildlife • Aquatic life • Terrrestial life • Ecosystem • Flora • Fauna

  16. Biodistribution

  17. Federal oversight • NNI has provisions for funding for environmental, health, and safety studies (EHS) • Under the Nanoscale Science, Engineering, and Technology subcommittee (NSET), Nanotechnology Environmental Health Implications working group (NEHI WG) functions as an interagency forum on understanding potential risks of nanotech.

  18. NNI EHS Document • Strategy for Nanotechnology-relatedEnvironmental, Health, and SafetyResearch • In FY2006, $68 millioninvested into 246 projects at 7 agencies. • Summarizesprimaryresearchcategories: • Instrumentation, Metrology, and AnalyticalMethods • Nanomaterials and Human Health • Nanomaterials and the Environment • Human and EnvironmentalExposureAssessment • Risk Management Methods

  19. Strategy for Nanotechnology-related Environmental, Health, and Safety research • Who is responsible? • National Institute for Standards and Technology (NIST) • Instrumentation, metrology, and analytical methods • National Institutes of Health (NIH) • Nanomaterials and human health • Environmental Protection Agency (EPA) • Nanomaterials and the environment • National Institutes of Occupational Safety and Health (NIOSH) • Human and environmental exposure assessment • Food and Drug Administration (FDA) • Risk management (also EPA)

  20. Role of nanotechnology-related EHS research in risk management of nanomaterials

  21. Key Words of Toxicology Dose / Response Hazard X Exposure = Risk Individual Susceptibility

  22. Research at the UW • Toxicology of Quantum Dots • Kavanagh (DEOHS) • Gao (BIOE) • Multiple in vitro cell lines • Transgenic mice • Various routes of exposure

  23. Applications of Qdots • Medical imaging • Cancer • Diagnostics • Therapeutics • Biological imaging agent • “Tag” proteins • Monitor cellular uptake Gao, Nature,

  24. Why are Qdots special?

  25. Why examine the liver? • Primary site of xenobiotic metabolism • Common site of toxicity • Resident macrophages sequester • bacteria from gut http://www.flickr.com/photos/mitopencourseware/

  26. Architecture of liver sinusoid http://www.flickr.com/photos/mitopencourseware/

  27. Experimental setup • Dose-response relationships evaluated: • Uptake • Viability (MTT) • GSH levels • Cell death

  28. Disposition of Qdots in cultured human hepatocytes

  29. Summary and conclusions • Qdots are sequestered by a subpopulation of cells in human hepatocyte cultures • Stable Qdots have no effect on viability of human hepatocytesin vitro • Thus far, this preparation of Qdots does not appear to be hepatotoxic

More Related